Latest Breaking News On - Carles berloso - Page 1 : comparemela.com

The WIN-B is a Phase Ib/II investigator-sponsored trial (IST) that will evaluate the safety and preliminary efficacy of the Debiopharm's potent Wee-1 inhibitor Debio 0123 in combination with Gilead's

City ofUnited kingdomUnited statesJavier cortDebiopharm debioTim robinsonSacituzumab govitecan trodelvySelva rajanEsteban rodrigo imedioCarles berlosoAmerican association for cancer researchUniversity of bristolAmerican cancer societyHead of communicationsGilead sciences incInternational pr comms